Trammell Crow Company has signed a lease with Chan Zuckerberg Biohub Chicago (CZ Biohub Chicago), a new biomedical research institute that brings together scientists from Northwestern University, the University of Chicago, and the University of Illinois Urbana-Champaign. CZ Biohub Chicago will occupy 25,698 square feet of space at 1375 West Fulton, which is part of TCC’s two-building, 725,000-square-foot Fulton Labs Campus in Chicago’s Fulton Market neighborhood.

1375 W. FultonTrammell Crow Company

“We are excited to welcome Chan Zuckerberg Biohub Chicago to our Fulton Labs Campus this spring. Their organization is on the cutting edge of biotech discovery and development. We are humbled that they chose the flourishing advanced sciences ecosystem at Fulton Labs as their new home,” said Johnny Carlson, Principal with TCC’s Midwest office. 

1375 W. FultonTrammell Crow Company

Announced earlier this month, CZ Biohub Chicago is part of the Chan Zuckerberg Biohub Network, a groundbreaking collaborative model for scientific research that brings together leading research institutions in different geographical regions. CZ Biohub Chicago researchers will engineer technologies to make precise, molecular-level measurements of biological processes within human tissues, with an ultimate goal of understanding and treating the inflammatory states that underlie many diseases.

1375 W. FultonTrammell Crow Company

“We’re excited for CZ Biohub Chicago to move into its own dedicated space with state-of-the-art labs, in an area of the city that is considered a hub for innovation in the life sciences,” said Shana O. Kelley, CZ Biohub Chicago President and the Neena B. Schwartz Professor of Chemistry and Biomedical Engineering at Northwestern University. 

The Fulton Labs Campus is located at 1375 West Fulton, which includes 300,000 square feet and features a Science-Ready Lab Suites program, and 400 North Aberdeen, which spans 425,000 square feet and opened in Q1 2022. Other tenants at the campus include Dimension Inx, Celadyne Technologies, Portal Innovations, Charles River Laboratories, Xeris Pharmaceuticals, Vanqua Bio and Talis Biomedical.